24 Recruiting Opioid Use Disorder Phase 2 Clinical Trials
Active phase 2 studies for opioid use disorder enrolling across the USA. Verify eligibility and contact site coordinators.
All Opioid Use Disorder studiesPhase 2 Studies for Opioid Use Disorder
Extended-release Buprenorphine as a Novel Low-dose Induction Strategy
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Sublingual Dexmedetomidine for Treating Opioid Withdrawal
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement
📍 University of California, San Diego — La Jolla, California
View Study & Checklist ➔Dynamic Treatment Regimes for Opioid Use Disorder
📍 Discovery Behavioral Health — Irvine, California
View Study & Checklist ➔Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder
📍 Tolan Park Medical Building — Detroit, Michigan
View Study & Checklist ➔Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
📍 VCU Institute for Drug and Alcohol Studies — Richmond, Virginia
View Study & Checklist ➔E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
📍 NYU Langone Health — New York, New York
View Study & Checklist ➔A Bundled Intervention
📍 UAB — Birmingham, Alabama
View Study & Checklist ➔A Study of Brenipatide in Participants With Opioid Use Disorder
📍 NoesisPharma - Phoenix - East Shea Boulevard — Phoenix, Arizona
View Study & Checklist ➔Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy
📍 Rapid Access Addiction Clinic (RAAC), St. Paul's Hospital — Vancouver, British Columbia
View Study & Checklist ➔Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
📍 Brown University — Providence, Rhode Island
View Study & Checklist ➔Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
📍 Gateway Community Services — Jacksonville, Florida
View Study & Checklist ➔GLP-1R Agonist Treatment for Opioid Use Disorder
📍 University of Maryland Baltimore — Baltimore, Maryland
View Study & Checklist ➔Ketamine for Opioid Use Disorder
📍 University of Maryland Addiction Programs and Affiliated Clinics — Baltimore, Maryland
View Study & Checklist ➔Remotely Observed Methadone Evaluation II
📍 FGC Wabash — Chicago, Illinois
View Study & Checklist ➔Divided or Single Exposure (DOSE) Study
📍 Addiction Treatment Services (ATS) — Baltimore, Maryland
View Study & Checklist ➔Wellcome Leap Psilocybin for OUD
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔Psilocybin for Opioid Use Disorder (OUD)
📍 Duke City Recovery Toolbox — Albuquerque, New Mexico
View Study & Checklist ➔Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
📍 Johns Hopkins Center for Psychedelic and Consciousness Research — Baltimore, Maryland
View Study & Checklist ➔Psilocybin on Brain Mechanisms of Motivation in OUD
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use
📍 University of Pennsylvania Center for Studies of Addiction — Philadelphia, Pennsylvania
View Study & Checklist ➔Ketones for Opioid Craving
📍 Caron Pennsylvania Addiction Treatment and Rehab Center — Wernersville, Pennsylvania
View Study & Checklist ➔Evaluating Buspirone to Treat Opioid Withdrawal
📍 Kahlert Institute for Addictino Medicin — Baltimore, Maryland
View Study & Checklist ➔Semaglutide for Helping Opioid Recovery
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔